Validea

Below is Validea’s guru fundamental report for MASTERCARD INC (MA). Of the 22 guru strategies we follow, MA rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low […]

The following are today’s upgrades for Validea’s Growth/Value Investor model based on the published strategy of James P. O’Shaughnessy. This two strategy approach offers a large-cap value model and a growth approach that looks for persistent earnings growth and strong

Below is Validea’s guru fundamental report for PEPSICO INC (PEP). Of the 22 guru strategies we follow, PEP rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low

Below is Validea’s guru fundamental report for NVIDIA CORP (NVDA). Of the 22 guru strategies we follow, NVDA rates highest using our Twin Momentum Investor model based on the published strategy of Dashan Huang. This momentum model looks for a

Below is Validea’s ETF fundamental report for iShares S&P 500 Value Index Fund ETF (IVE). The report looks at IVE’s exposure to the major investing factors including value, quality, momentum and low volatility. iShares S&P 500 Value Index Fund ETF

Below is Validea’s guru fundamental report for DOORDASH INC (DASH). Of the 22 guru strategies we follow, DASH rates highest using our Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy looks for small cap

Below is Validea’s guru fundamental report for MASTERCARD INC (MA). Of the 22 guru strategies we follow, MA rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low

Below is Validea’s guru fundamental report for CRINETICS PHARMACEUTICALS INC (CRNX). Of the 22 guru strategies we follow, CRNX rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for

Below is Validea’s guru fundamental report for LAM RESEARCH CORPORATION (LRCX). Of the 22 guru strategies we follow, LRCX rates highest using our Patient Investor model based on the published strategy of Warren Buffett. This strategy seeks out firms with